Rare neoplastic disease Advocacy Hub | UniteRare

At a Glance

Live from database

Regulatory Watchboard

10 events

Jun 2027Zipalertinib With Carboplatin and Pemetrexed for the Treatment of Resectable, Stage II-IIIB, Non-Small Cell Lung Cancer

Jonsson Comprehensive Cancer Center — PHASE2

TrialNOT YET RECRUITING

Apr 2026NCI Childhood Cancer Data Initiative (CCDI) Led Pediatric, Adolescent, and Young Adult Rare Cancer Registry for Very Rare Solid Tumors

National Cancer Institute (NCI)

TrialNOT YET RECRUITING

Feb 2026International Multicentric Retrospective Study on the Use of EV+P as First-line Therapy in Patients With la/mUC

Aron Research Foundation Ets

TrialNOT YET RECRUITING

Jan 2026Rare Tumor Focused Platform Study of Innovative Therapies and Technologies (PLATFORM2)

Cancer Institute and Hospital, Chinese Academy of Medical Sciences — PHASE1, PHASE2

TrialNOT YET RECRUITING

Jan 2026Firmonertinib Combined With Definitive Radiotherapy in Stage III Unresectable EGFR Uncommon Mutant Pulmonary Adenocarcinoma

Hunan Cancer Hospital — PHASE2

TrialNOT YET RECRUITING

Dec 2025A Study to Assess the Efficacy and Safety of Zipalertinib Versus Placebo for Adjuvant Treatment in Participants With Stage IB-IIIA NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection

Taiho Oncology, Inc. — PHASE3

TrialRECRUITING

Jul 2025Pragmatic Analysis of Complex Radiotherapy Cases In Cancer of the Lung

The Christie NHS Foundation Trust

TrialACTIVE NOT RECRUITING

Jul 2025Performance Indicators and Impact on the Care Pathway of Sequencing on the SeqOIA and AURAGEN (Seqogen) Platforms for Oncology Patients

Assistance Publique - Hôpitaux de Paris

TrialRECRUITING

Apr 2025Treatment Guided by Comprehensive Genome and Transcriptome Analysis Versus Standard of Care in Advanced Rare Cancers

German Cancer Research Center

TrialNOT YET RECRUITING

Mar 2025Precision Cancer Therapy in Rare Cancers

Oslo University Hospital — PHASE2

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

Total programs

No financial assistance programs currently listed for Rare neoplastic disease.
Check the disease page for updates →

Clinical Trial Landscape

2 active trials

1Phase 2

1Unknown

2Total recruiting

Search clinical trials for Rare neoplastic disease →

Recent News & Research

No recent news articles indexed yet for Rare neoplastic disease.
Search PubMed for Rare neoplastic disease →

Browse all Rare neoplastic disease news →

Specialist Network

Top 6 by expertise

Matthew Krebs, Dr

The Christie Hospital

Score 387 trials

Andrea B Apolo

National Cancer Institute LAO

📍 Birmingham, Alabama

Score 174 trials

Hongxia Wang, Doctor

Fudan University

Score 162 trials

Morgan Lam

ArriVent BioPharm

Score 113 trials9 pubs

Alice P Chen, M.D.

National Cancer Institute (NCI)

Score 109 trials

Silvia Stacchiotti, MD

Fondazione IRCCS INT di Milano

Score 104 trials

View all Rare neoplastic disease specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰